NASH - Nonalcoholic Steatohepatitis Recruiting Phase 2 Trials for Tocotrienol (DB12647)

IndicationStatusPhase
DBCOND0088313 (NASH - Nonalcoholic Steatohepatitis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02581085Tocotrienol Against the Progression of End Stage Liver DiseaseOther